Nothing Special   »   [go: up one dir, main page]
Skip to main content

Advertisement

Springer Nature Link
Log in

Fatigue and progression of corpus callosum atrophy in multiple sclerosis

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Fatigue is one of the most disabling symptoms in multiple sclerosis (MS) patients. There is no or only weak correlation between conventional magnetic resonance imaging (MRI) parameters and level of fatigue. The aim of this study was to investigate the relationship between progression of corpus callosum (CC) atrophy and fatigue in MS patients. This was a cohort study in 70 patients with relapsing form of MS (RRMS) and serial MRIs over a mean follow-up of 4.8 years [67% female, mean age 42 ± 11 years, mean disease duration 9.7 ± 7.6 years, mean Expanded Disability Status Scale (EDSS) 2.8 ± 1.6]. Fatigue was assessed by the Fatigue Severity Scale (FSS). CC size was measured with the CC index (CCI). In total, 40% of the patients suffered from fatigue (mean FSS score 5.3 ±1.1) and 60% patients had no fatigue (mean FSS score of 2.1 ± 1). Patients with fatigue had higher EDSS scores (p = 0.01) and CC atrophy was more pronounced in patients with fatigue (−21.8 vs. −12.1%, p = 0.005). FSS correlated with CCI change over time (r = −0.33; p = 0.009) and EDSS (p = 0.008; r = 0.361). The association between annualized CCI change and FSS was independent from EDSS, disease duration, gender and age in a multivariate linear regression analysis (p < 0.001). Progression of CC atrophy may play a role in the evolution of MS-related fatigue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Anderson VM, Fox NC, Miller DH (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 23:605–618

    Article  PubMed  Google Scholar 

  2. Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, Stengel LM, Ekes R, Kinkel PR (1999) Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 53:1151–1153

    PubMed  CAS  Google Scholar 

  3. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6:181–185

    PubMed  CAS  Google Scholar 

  4. Barkhof FJ, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, Polman CH, Kok A, Valk J (1998) Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J Neurol 245:153–158

    Article  PubMed  CAS  Google Scholar 

  5. Beck AT, Brown GK, Steer RA (1997) Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther 35:1039–1046

    Article  PubMed  CAS  Google Scholar 

  6. Chard DT, Griffin CM, Rashid W, Davies GR, Altmann DR, Kapoor R, Barker GJ, Thompson AJ, Miller DH (2004) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 10:387–391

    Article  PubMed  CAS  Google Scholar 

  7. Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363:978–988

    Article  PubMed  Google Scholar 

  8. Codella M, Rocca MA, Colombo B, Martinelli-Boneschi F, Comi G, Filippi M (2002) Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 194:71–74

    Article  PubMed  CAS  Google Scholar 

  9. Codella M, Rocca MA, Colombo B, Rossi P, Comi G, Filippi M (2002) A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 249:535–537

    Article  PubMed  Google Scholar 

  10. Colombo B, Martinelli BF, Rossi P, Rovaris M, Maderna L, Filippi M, Comi G (2000) MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 247:506–509

    Article  PubMed  CAS  Google Scholar 

  11. Figueira FF, Santos VS, Figueira GM, Silva AC (2007) Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr 65:931–935

    Article  PubMed  Google Scholar 

  12. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559–567

    Article  PubMed  CAS  Google Scholar 

  13. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9–14

    PubMed  CAS  Google Scholar 

  14. Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45:33–38

    Article  PubMed  CAS  Google Scholar 

  15. Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135–138

    PubMed  CAS  Google Scholar 

  16. Ge Y, Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL (2001) Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220:606–610

    Article  PubMed  CAS  Google Scholar 

  17. Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM, Davis KR (1991) Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 180:215–221

    PubMed  CAS  Google Scholar 

  18. Giovannoni G, Thompson AJ, Miller DH, Thompson EJ (2001) Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology 57:676–681

    PubMed  CAS  Google Scholar 

  19. Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-Coutinho M, Clanet M, Radue EW, Kappos L (2003) Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis. Arch Neurol 60:1736–1739

    Article  PubMed  Google Scholar 

  20. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437

    PubMed  CAS  Google Scholar 

  21. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123

    PubMed  CAS  Google Scholar 

  22. Krupp LB, Pollina DA (1996) Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 9:456–460

    Article  PubMed  CAS  Google Scholar 

  23. Mainero C, Faroni J, Gasperini C, Filippi M, Giugni E, Ciccarelli O, Rovaris M, Bastianello S, Comi G, Pozzilli C (1999) Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 246:454–458

    Article  PubMed  CAS  Google Scholar 

  24. Marrie RA, Fisher E, Miller DM, Lee JC, Rudick RA (2005) Association of fatigue and brain atrophy in multiple sclerosis. J Neurol Sci 228:161–166

    Article  PubMed  Google Scholar 

  25. Martola J, Stawiarz L, Fredrikson S, Hillert J, Bergstrom J, Flodmark O, Kristoffersen WM (2007) Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J Neurol Neurosurg Psychiatry 78:375–380

    PubMed  Google Scholar 

  26. Mesaros S, Rocca MA, Riccitelli G, Pagani E, Rovaris M, Caputo D, Ghezzi A, Capra R, Bertolotto A, Comi G, Filippi M (2009) Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp 30:2656–2666

    Article  PubMed  Google Scholar 

  27. Niepel G, Tench C, Morgan PS, Evangelou N, Auer DP, Constantinescu CS (2006) Deep gray matter and fatigue in MS: a T1 relaxation time study. J Neurol 253:896–902

    Article  PubMed  CAS  Google Scholar 

  28. Nocentini U, Rossini PM, Carlesimo GA, Graceffa A, Grasso MG, Lupoi D, Oliveri M, Orlacchio A, Pozzilli C, Rizzato B, Caltagirone C (2001) Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings. Eur Neurol 45:11–18

    Article  PubMed  CAS  Google Scholar 

  29. Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Cherif AA (2001) A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58:105–111

    Article  PubMed  CAS  Google Scholar 

  30. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H (2006) Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 243:39–45

    Article  PubMed  CAS  Google Scholar 

  31. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  32. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 39:161–166

    PubMed  CAS  Google Scholar 

  33. Riccitelli G, Rocca M, Forn C, Colombo B, Comi G, Filippi M (2010) Definition of regional distribution of grey matter loss in multiple sclerosis patients with fatigue: a voxel-based morphometry study. J Neurol 257:S1–S246

    Google Scholar 

  34. Rocca MA, Agosta F, Colombo B, Mezzapesa DM, Falini A, Comi G, Filippi M (2007) fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection. Hum Brain Mapp 28:373–382

    Article  PubMed  Google Scholar 

  35. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radu EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566–1571

    PubMed  CAS  Google Scholar 

  36. Schreiber K, Sorensen PS, Koch-Henriksen N, Wagner A, Blinkenberg M, Svarer C, Petersen HC (2001) Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurol Scand 104:24–30

    Article  PubMed  CAS  Google Scholar 

  37. Simioni S, Ruffieux C, Bruggimann L, Annoni JM, Schluep M (2007) Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly 137:496–501

    PubMed  CAS  Google Scholar 

  38. Simon JH, Holtas SL, Schiffer RB, Rudick RA, Herndon RM, Kido DK, Utz R (1986) Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. Radiology 160:363–367

    PubMed  CAS  Google Scholar 

  39. Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De SN, Lapierre Y, Arnold DL (2004) The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61:201–207

    Article  PubMed  Google Scholar 

  40. Van Der Werf SP, Jongen PJ, Nijeholt GJ, Barkhof F, Hommes OR, Bleijenberg G (1998) Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci 160:164–170

    Article  PubMed  Google Scholar 

  41. Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N (2010) Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol 257:1256–1264

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

OY reports receiving travel grants, advisory, consulting and lecture fees from Bayer Schering, Biogen Idec, Novartis and Merck Serono which are exclusively used for research at the University of Basel, department of neurology. NP reports that he is now an employee of Biogen Idec. He had previously received honoraria, travel grants, research grants and personal compensation from Bayer Healthcare, Biogen Idec, GSK, TEVA, Sanofi Aventis, Merck Serono and Novartis. BT has received travel grants and honoraria from Merck Serono, Biogen Idec and Bayer Healthcare. AG and AP had nothing to disclose.

Author information

Authors and Affiliations

  1. Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

    Özgür Yaldizli, Stephanie Glassl, Dietrich Sturm, Barbara Tettenborn & Norman Putzki

  2. Department of Neurology/Neuroradiology, University of Basel, Basel, Switzerland

    Athina Papadopoulou & Achim Gass

  3. Department of Neurology, University of Basel, Petersgraben 4, 4031, Basel, Switzerland

    Özgür Yaldizli

Authors
  1. Özgür Yaldizli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Glassl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dietrich Sturm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Athina Papadopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Achim Gass
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Barbara Tettenborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norman Putzki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Özgür Yaldizli.

Electronic supplementary material

Below is the link to the electronic supplementary material.

415_2011_6091_MOESM1_ESM.doc

Fatigue severity scale. Each patient is asked to respond to the following nine statements by choosing a number between one and seven, where one indicates strongly disagree and seven indicates strongly agree. FSS mean score >4 indicates severe fatigue [21]

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yaldizli, Ö., Glassl, S., Sturm, D. et al. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 258, 2199–2205 (2011). https://doi.org/10.1007/s00415-011-6091-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-6091-0

Keywords

Search

Navigation